Care pathways & referral

The ASCO Drug Race Still Runs Through Genomic Testing

High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts

Alzheimer’s Blood Testing Moves the Disease Clock Earlier

Lenacapavir Turns HIV Prevention Into an Access Stress Test

WHO’s New AMR Plan Makes Stewardship and Access a Single Test

Physical activity continues to strengthen its case as a cross-disease prevention strategy

Can cortisol become the next target in type 2 diabetes?

Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks

An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
